Skip to main content
. 2008 Mar 31;52(6):2260–2262. doi: 10.1128/AAC.01270-07

TABLE 2.

Macrolide resistance genes, phenotypes, and serotypes of erythromycin-nonsusceptible isolates

Gene(s) mef subclass Phenotype No. of isolates MIC range (μg/ml)
Serotype(s) (no. of isolates)
Erythromycin Clindamycin
mef (15 [19.7])a mef(E) M 8 1-8 0.015-0.06 6A (1), 6B (2), 19A (1), 19F (1), 23F (1), 35F (1), NTb (1)
mef(I)c M 5 2-8 0.015-0.06 6A (2), 11B (1), NT (2)
mefd M 2 8-16 0.03 9A (1), 13(1)
erm(B) (38 [50.0]) iMcLS 27 2-≥32 2-≥32 3 (3), 6A (2), 6B (15), 14 (2), 19F (2), 35C (1), NT (2)
iMcLS (NBe) 2 ≥32 ≥32 6A (1), 6B (1)
cMLS 9 ≥32 ≥32 6A (1), 19A (1), 19F (3), 23F (2), 35F (1), NT (1)
erm(B) + mef(E) iMcLS (NB) 2 ≥32 ≥32 23F (2)
    (23 [30.3]) cMLS 21 ≥32 8-≥32 19F (4), 23F (16), NT (1)
a

Data in parentheses represent the number (percent) of isolates.

b

NT, nontypeable.

c

For three of these isolates, mef(I) was assigned on the basis of sequencing of an internal fragment.

d

Similarity of 99% with mef from a Bacteroides ovatus strain with GenBank accession number AJ557257.

e

NB, no blunting of inhibition zone around rokitamycin.